PTGX fund manager activity
Protagonist Therapeutics, Inc · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q3 2019 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | Added | 16,000 | $1,961,280 | 0.00% | Aug 14, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | Added | 208,900 | $25,607,000 | 0.59% | Aug 14, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 170,524 | $20,902,831 | 0.01% | Aug 4, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 18,663 | $2,287,711 | 0.01% | Aug 14, 2026 |
| Polen Capital Management | Trimmed | 22,651 | $2,776,560 | 0.02% | Aug 4, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | Added | 15,000 | $1,581,000 | 0.00% | May 15, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | No change | 159,700 | $16,832,000 | 0.57% | May 15, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 173,971 | $18,336,542 | 0.01% | May 5, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 21,155 | $2,229,737 | 0.01% | May 15, 2026 |
| Polen Capital Management | Added | 24,337 | $2,565,120 | 0.02% | May 14, 2026 |
Older quarters